ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK 2200 PE (PUT) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

Live Options price premium & chart analysis for GLENMARK 2200 PE (PUT) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited GLENMARK trades in NSE under Pharmaceuticals NSE

GLENMARK 2200 PE Live prices

What is premium price of GLENMARK 2200 PE PUT today?
Premium of GLENMARK 2200 PE is 172.00 on 26 Dec 2025 PUT opened at 0.00 and traded inside a Low-High range of 0.00-0.00 today. Please click here table for more current prices.
What is open interest of GLENMARK 2200 PUT PE today?
Open Interest of GLENMARK 2200 PE is 4500 today. This has changed 0.00 from previous day.
What is underlying price of GLENMARK 2200 PE PUT today?
Underlying price of GLENMARK 2200 PE PUT is 2010.60 today.
What is lot size of GLENMARK 2200 PUT PE today?
Lot size of GLENMARK 2200 PUT PE is 375.00
Is GLENMARK 2200 PE PUT ITM or OTM or ATM?
GLENMARK 2200 PUT PE is ITM PUT option (in the money). Only ITM options have intrinsic value in them, while OTM options have only time value in them.

Underlying equity prev closing: 2010.60

GLENMARK PUT PE available options strikes

PE 1920, PE 1940, PE 1960, PE 1980, PE 2000, PE 2020, PE 2040, PE 2060, PE 2080, PE 2100, All CE , All PE

GLENMARK 2200 PUT PE available expiry dates

30 Dec 202527 Jan 202624 Feb 2026

Premium of GLENMARK 2200 PUT PE January 27 2026

GLENMARK 2200 PE Live prices

Premium of PUT (PE) of strike 2200 is at: 172.00 on 26 Dec 2025
PUT opened at 0.00 and traded inside a Low-High range of 0.00-0.00 as on 26 Fri Dec 2025

The underlying equity is trading at 2010.60 which means that PUT of strike 2200 is ITM PUT option (in the money)

Lot size of GLENMARK Glenmark Pharmaceuticals Limited is 375

Total Open Interest for PUT (PE) of strike 2200 is 4,500

Price action analysis of 2200 PUT based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Price action analysis of 2200 PUT based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

Click here to view most profitable CE and PE for Glenmark Pharmaceuticals Limited, both for buyers and sellers | GLENMARK Most Active Call Put Options

Date Underlying price PE price PE open PE high PE low PE volume PE OI OI Change
26 Fri Dec 2010.60 172.00 0.00 0.00 0.00 0 1,687,500 0%
24 Wed Dec 2020.10 172.00 172.00 172.00 172.00 9 1,687,500 -29.4%
23 Tue Dec 2047.00 157.00 146.00 157.00 145.00 -28 2,390,625 88.9%
22 Mon Dec 2038.20 219.45 0.00 0.00 0.00 0 1,265,625 0%
19 Fri Dec 1992.10 219.45 0.00 0.00 0.00 0 1,265,625 0%
18 Thu Dec 1957.10 219.45 0.00 0.00 0.00 0 1,265,625 0%

Charts for GLENMARK 2200 PUT PE options for Glenmark Pharmaceuticals Limited

Select an expiry and a strike price below to view charts for those options. GLENMARK All in One charts

Charts for:      

Dark shadowed line on the chart below is the current SPOT price line of underlying equity. White line on the chart is the option closing price line. Candle sticks on the chart are the OHLC for the option.

GLENMARK 2200 PE (PUT) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

GLENMARK further analysis

GLENMARK 2200 PE (PUT) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

These are GLENMARK 2200 PE (PUT) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited . Click the links below to switch between charts

 

Videos related to: GLENMARK 2200 PE (PUT) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Basics How To Trade In FnO Futures Options Stock Market

GLENMARK 2200 PE (PUT) 27 January 2026 options price chart analysis Glenmark Pharmaceuticals Limited

 

Back to top